The Drug Enforcement Administration received the "Report on the Drug Enforcement Administration Foreign Operations Review," which contains findings and recommendations to assess our foreign operations, enhance our integrity efforts, and maximize the impact of our global work. DEA requested the comprehensive review in August 2021 to evaluate the strengths and...

Xylazine, reported as an adulterant in an increasing number of illicit drug mixtures, has also been detected in a growing number of overdose deaths. It is commonly encountered in combination with fentanyl but has also been detected in mixtures containing cocaine, heroin, and a variety of other drugs. However, xylazine...

This report delves into the activities of these criminals and their methods. Drug trafficking operations benefit from a number of different actors, such as brokers, cooks, envoys, intermediaries, and money laundering service providers. Examples of the methods used by the criminals include the corruption of officials in the public and...

This document is an internal Drug Enforcement Administration quality system document which provides a summary of validated quantitative and qualitative methods. The document is updated periodically and current as of December 7th, 2022, and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted...

This document is an internal Drug Enforcement Administration quality system document which provides a summary of validated quantitative and qualitative methods. The document is updated periodically and current as of December 7th, 2022, and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted...

The DEA’s Fentanyl Profiling Program (FPP) performs in-depth chemical analyses on fentanyl and fentanyl-related samples obtained from seizures throughout the United States. This report summarizes the findings for these analyses for Calendar Year 2021. FPP data is not intended to reflect U.S. market share, but is rather a snapshot of...

La DEA está observando un repunte en todo el país de sucesos de sobredosis masivas relacionados con el fentanilo que implican tres o más sobredosis que ocurren cerca en el tiempo en el mismo lugar. Solo en los dos últimos meses, al menos 7 eventos confirmados de sobredosis masiva en...

The DEA is seeing a nationwide spike in fentanyl-related mass-overdose events involving three or more overdoses occurring close in time at the same location. In just the past two months, there have been at least 7 confirmed mass overdose events across the United States resulting in 58 overdoses and 29...

DEA officials report a dramatic rise in the number of fake pills containing at least 2 mg of fentanyl, which is considered a deadly dose.

What is it? Many counterfeit pills are made to look like prescription opioids – such as oxycodone (Oxycontin®, Percocet®), hydrocodone (Vicodin®), and alprazolam (Xanax®); or stimulants like amphetamines (Adderall®) – but contain fentanyl or methamphetamine. Criminal drug networks are mass-producing fake pills and falsely marketing them as legitimate prescription pills...